Phase III: 8 molecules
Phase II: 10 molecules
Phase I: 30 molecules
The compounds and their uses mentioned on this website are investigational and have not been approved by the US Food and Drug Administration. Efficacy and safety have not been established. The information presented should not be construed as a recommendation for use. The relevance of findings in preclinical studies to humans is currently being evaluated.
An error occurred while loading this portion of content. We are resolving this issue and apologize for the inconvenience.
Please check back soon for an update.
aDeveloped in collaboration with Array BioPharma. bIgnyta, Inc acquisition. cDeveloped in collaboration with Seattle Genetics. dJoint project with AbbVie. eDeveloped in collaboration with Exelixis. fDeveloped in collaboration with Chugai. gDeveloped in collaboration with BioNTech.
- Roche first-quarter results 2019 presentation. https://www.roche.com/dam/jcr:f03df0f2-852c-47a5-9924-343bfb239c37/en/irp190417.pdf. Accessed April 18, 2019.